Institutional Ownership Vor Biopharma Inc. (VOR)
This table provides information about the institutional ownership of Vor Biopharma Inc. (VOR). We have compiled data on the 57 institutions that hold shares in the stock, with a total of 41.2 Million shares, which have been reported (via 13F filing form) to have a value of $32.9 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Hsbc Holdings PLC
London, X0 |
Nov 14, 2024 Q3 2024 |
44,728
shares
|
$35,335
0.0% of portfolio
|
Q3 2024
Reduced 8.79%
|
|
|
Nomura Holdings Inc
Tokyo, M0 |
Nov 14, 2024 Q3 2024 |
41,495
shares
|
$32,781
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2024 Q3 2024 |
30,825
shares
|
$24,351
0.0% of portfolio
|
Q3 2024
Reduced 67.68%
|
|
|
Point72 Asia (Singapore) Pte. Ltd.
Singapore, U0 |
Nov 14, 2024 Q3 2024 |
29,530
shares
|
$23,328
0.0% of portfolio
|
Q3 2024
Reduced 53.32%
|
|
|
Laurion Capital Management LP
New York, NY |
Nov 14, 2024 Q3 2024 |
28,981
shares
|
$22,894
0.0% of portfolio
|
Q3 2024
Reduced 98.85%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
28,227
shares
|
$22,299
0.0% of portfolio
|
Q3 2024
Reduced 92.48%
|
|
|
Ground Swell Capital, LLC
Folly Beach, SC |
Oct 29, 2024 Q3 2024 |
26,103
shares
|
$20,621
0.02% of portfolio
|
Q3 2024
Added 26.26%
|
|
|
Money Concepts Capital Corp
|
Oct 31, 2024 Q3 2024 |
25,000
shares
|
$19,750
0.0% of portfolio
|
Q3 2024
Added 25.0%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
24,448
shares
|
$19,313
0.0% of portfolio
|
Q3 2024
Reduced 85.56%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 07, 2024 Q3 2024 |
24,219
shares
|
$19,133
0.0% of portfolio
|
Q2 2024
Reduced 2.81%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
17,792
shares
|
$14,055
0.0% of portfolio
|
Q2 2024
Reduced 82.88%
|
|
|
United Bank
Vienna, VA |
Nov 15, 2024 Q3 2024 |
15,300
shares
|
$12,087
0.0% of portfolio
|
Q2 2024
Added 40.37%
|
|
|
Grimes & Company, Inc.
|
Oct 22, 2024 Q3 2024 |
15,142
shares
|
$11,962
0.0% of portfolio
|
Q2 2024
Added 7.28%
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
13,761
shares
|
$10,871
0.0% of portfolio
|
Q3 2024
Reduced 93.82%
|
|
|
Chicago Partners Investment Group LLC
|
Oct 28, 2024 Q3 2024 |
13,593
shares
|
$10,738
0.0% of portfolio
|
Q3 2024
Reduced 17.48%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 08, 2024 Q3 2024 |
12,038
shares
|
$9,510
0.0% of portfolio
|
Q3 2024
Added 1124.62%
|
|
|
Barclays PLC
London, X0 |
Nov 19, 2024 Q3 2024 |
11,024
shares
|
$8,708
0.0% of portfolio
|
Q3 2024
Reduced 57.19%
|
|
|
Chiron Capital Management, LLC
|
Nov 14, 2024 Q3 2024 |
11,000
shares
|
$8,690
0.01% of portfolio
|
Q3 2024
New holding
|
|
|
Catalyst Funds Management Pty LTD
Sydney Nsw, C3 |
Nov 14, 2024 Q3 2024 |
9,800
shares
|
$7,742
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2024 Q3 2024 |
5,871
shares
|
$4,638
0.0% of portfolio
|
Q3 2024
Reduced 76.67%
|
|
|
Simplex Trading, LLC
|
Nov 08, 2024 Q3 2024 |
5,053
shares
|
$3,991
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Tower Research Capital LLC (Trc)
New York, NY |
Nov 14, 2024 Q3 2024 |
4,298
shares
|
$3,395
0.0% of portfolio
|
Q3 2024
Reduced 72.47%
|
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Nov 13, 2024 Q3 2024 |
3,759
shares
|
$2,969
0.0% of portfolio
|
Q3 2024
Added 4.42%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
713
shares
|
$563
0.0% of portfolio
|
Q3 2024
Reduced 99.16%
|
|
|
Srs Capital Advisors, Inc.
Denver, CO |
Nov 06, 2024 Q3 2024 |
528
shares
|
$417
0.0% of portfolio
|
Q2 2024
New holding
|